Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 697 40 345.9 |
96 | EP file number | EAKZ | 05 07 6131.1 |
97 | EP publication number | EPN | 1593393 |
54 | Designation/title | TI | Anti-TNF Antikörper und Methotrexat zur Behandlung von Autoimmunkrankheiten |
51 | IPC main class | ICM (ICMV) | A61K 39/395 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 38/17 (2006.01), A61K 31/505 (2006.01), A61P 37/00 (2006.01), C07K 16/24 (2006.01) |
22 | DE application date | DAT | Aug 1, 1997 |
96 | EP application date | EAT | Aug 1, 1997 |
43 | Date of first publication | OT | Nov 9, 2005 |
| Date of publication of grant | PET | Nov 30, 2011 |
71/73 | Applicant/owner | INH | The Kennedy Trust for Rheumatology Research, London, GB |
72 | Inventor | IN | Feldman, Marc, London N6 4QT, GB; Maini, Ravinder Nath, London SW13 9EW, GB |
74 | Representative | VTR | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE |
| Address for service | | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 690775 Aug 1, 1996
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2012 000 037.3 12 2012 000 036.5 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001593393 Searchable text:
EP000001593393 Original document:
EP000001593393B1 Searchable text:
EP000001593393B1 |
43 | Date of first publication | EVT | Nov 9, 2005 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 23, 2023 (Show all update days)(Hide all update days)- May 27, 2011
- Date of the first transfer into DPMAregister
|